Mandate

Vinge advises Investor on Agnafit Bidco’s public offer for Sobi

September 02, 2021 Capital Markets and Public M&A

Agnafit Bidco has announced a public offer to the shareholders of Swedish Orphan Biovitrum AB (publ).

The total value of the offer is approximately SEK 69.4 billion.

Vinges team mainly includes public M&A partner Erik Sjöman that advises Investor AB (publ), Sobi’s largest shareholder.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025